both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes

Is it okay to give patients both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes?

This is sometimes tried if patients need combo therapy and they want to avoid weight gain or hypoglycemia from other meds.

GLP-1 agonists mimic incretin hormones...while DPP-4 inhibitors, or "gliptins," prevent the breakdown of endogenous incretins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote